Can You Lose Weight from Ozempic? Exploring the Facts

Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide produces measurable weight loss by slowing stomach emptying and activating brain centers that regulate appetite. Clinical trials show patients using semaglutide lose between 10% and 22% of body weight over 68 weeks, depending on dose and individual response. PlexusDx delivers pharmaceutical-grade compounded semaglutide through licensed 503A pharmacies across all 50 states.

How Semaglutide Works for Weight Loss

Semaglutide mimics a natural hormone called GLP-1 that your pancreas releases after eating. This hormone tells your brain you feel full, slows the movement of food through your stomach, and reduces cravings for high-calorie foods. By activating GLP-1 receptors in multiple organs, semaglutide creates a sustained signal that extends beyond a single meal, which is why patients report reduced hunger throughout the day.

The weight loss effect begins within the first 2 to 4 weeks as appetite suppression takes hold. Most patients experience the strongest benefits between weeks 8 and 16 as their bodies adapt to the medication. Individual results vary based on genetics, starting weight, diet quality, and physical activity—factors that PlexusDx's Precision Peptide Genetic Test can help clarify by mapping how your specific genetic variants influence GLP-1 pathway sensitivity.

Clinical Evidence: Real Weight Loss Numbers

The STEP trials, which tracked over 4,500 adults with obesity, showed that semaglutide at the 2.4 mg dose produced an average weight loss of 15% of baseline body weight after one year. Patients receiving placebo lost only 2.4% on average. When participants continued treatment through year two, weight loss accumulated to approximately 17% for those on the active medication, demonstrating sustained benefit rather than a temporary drop.

Weight loss peaked around 40 to 68 weeks of consistent use, with most patients reaching their individual plateau by month 6. Studies also documented improvements in waist circumference, blood pressure, and metabolic markers like fasting glucose and HbA1c. These outcomes apply equally to compounded semaglutide from licensed 503A pharmacies, which contain the same active pharmaceutical ingredient as brand-name Ozempic.

Why Some People Lose More Weight Than Others

Genetic differences in the GLP-1 receptor gene (GLP1R rs6923761) and the GIPR gene (rs1800437) influence how strongly your body responds to semaglutide. Some individuals have genetic variants that enhance GLP-1 receptor expression, making them more sensitive to appetite suppression; others carry variants that dampen the response. This variation partly explains why identical doses produce weight losses ranging from 5% to 25% across different patients.

The FTO gene (rs9939609) and MC4R gene (rs17782313) also predict baseline hunger patterns and metabolic set point. Patients with certain FTO variants naturally gravitate toward higher calorie intake without pharmaceutical support. PlexusDx's Precision Peptide Genetic Test sequences these four key variants (plus 45 additional peptide-pathway markers) to forecast your likely response trajectory and help your provider optimize your treatment plan before committing to a full year of therapy.

Compounded Semaglutide vs. Brand-Name Ozempic: Same Mechanism, Different Access

Brand-name Ozempic and compounded semaglutide from licensed 503A pharmacies contain identical active ingredients and produce the same weight loss mechanism. The difference lies in sourcing, cost, and availability. Brand Ozempic requires insurance approval or out-of-pocket payment of $900–$1,200 monthly; PlexusDx compounded semaglutide injection starts at $149 per month with flat pricing across three commitment tiers. Neither the brand nor compounded version is covered under standard insurance pharmacy benefits, but both are HSA/FSA eligible.

Compounded semaglutide is prepared fresh by licensed 503A pharmacies under sterile conditions and must meet the same United States Pharmacopeia (USP) standards as brand medications. PlexusDx sources all compounded medications exclusively from 503A facilities (never 503B bulk manufacturers), ensuring traceability, quality control, and access without membership fees or insurance gatekeeping. Patients in all 50 states can begin therapy within days of completing a virtual consultation.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I lose weight on semaglutide?

Most patients notice appetite suppression within 1 to 2 weeks, but measurable weight loss typically appears after 4 to 8 weeks as your body adjusts to the medication. Significant weight loss (5% or more of baseline) usually emerges by week 12. PlexusDx patients on compounded semaglutide injection starting at $149/month follow the same timeline as brand-name users.

What percentage of weight do clinical trials show people lose?

The STEP trials documented average weight loss of 15% over 68 weeks on the 2.4 mg dose of semaglutide, compared to 2.4% on placebo. Individual results range from 5% to 22% depending on your genetics, adherence, and lifestyle factors. PlexusDx's Precision Peptide Genetic Test can predict your likely response range based on your GLP-1 pathway variants.

Why is compounded semaglutide so much cheaper than Ozempic?

PlexusDx uses compounded semaglutide from licensed 503A pharmacies, which bypass brand-name manufacturing and distribution markups. At $149/month flat (your dose may need to go up, your price won't), compounded semaglutide delivers the same active ingredient at a fraction of Ozempic's $900+ monthly cost. Both are HSA/FSA eligible and available without insurance.

Are there side effects I should know about?

Nausea, vomiting, constipation, and loss of appetite are common early side effects, typically mild and temporary. Serious side effects (pancreatitis, gallbladder issues, kidney concerns) are rare but require medical monitoring. PlexusDx includes ongoing provider support to manage side effects and adjust dosing; compounded semaglutide carries the same safety profile as brand Ozempic.

How does genetic testing help predict my weight loss on semaglutide?

PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence your natural hunger patterns and semaglutide sensitivity. Patients with certain GLP1R and GIPR variants show stronger appetite suppression; those with specific FTO variants may require higher doses for equivalent benefit. Testing at $99 (after your first month) helps your provider personalize your dose strategy and set realistic expectations.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Ozempic For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.